Jeffrey Persico, DMD
Oral and Maxillofacial Surgery · Lansing, MINPI 1437252509
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,000 of the $2,607 with a category attached, or 76.7%. Nobel Biocare USA accounts for 82.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $2,413 and has fallen 98.8% since, to $28 in 2025.
Across 17 payments — averaging $153.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nobel Biocare USA$2K
- Straumann USA LLC$154
- Salvin Dental Specialties, Inc.$150
- Zimmer Biomet$75
- Envista Holdings Corporation$28
- Dental Imaging Technologies Corp.$21
- plus $27 from 2 others
What the payments were for
- Speaking & faculty fees$2,00077%
- Food & beverage$43617%
- Education$1506%
- Gifts$211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nobel Biocare USA | 4 | $2,152 |
| Straumann USA LLC | 3 | $154 |
| Salvin Dental Specialties, Inc. | 5 | $150 |
| Zimmer Biomet | 1 | $75 |
| Envista Holdings Corporation | 1 | $28 |
| Dental Imaging Technologies Corp. | 1 | $21 |
| Zimvie Inc. | 1 | $14 |
| Henry Schein, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOBELPARALLEL$2,116
- NOBELACTIVE$2,116
How this compares
$2,607 in reported general payments places this provider in the 80th percentile of 231 oral and maxillofacial surgery providers in Michigan.
See all oral and maxillofacial surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 26 | $671 |
| Amoxicillin | 218 | $650 |
| Chlorhexidine Gluconate | 141 | $639 |
| Clindamycin Hcl | 41 | $304 |
| Ibuprofen | 59 | $158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $141 |
| Doxycycline Hyclate | 15 | $136 |
| Cephalexin | 16 | $123 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $60 |
| Azithromycin | 13 | $51 |
| Tramadol Hcl | 16 | $26 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Lansing
- Carlos Ramirez NeyraWarren$233K
- Sean EdwardsAnn Arbor$165K
- David WilsonPortage$34K
- Rushil DangDetroit$34K
- Paulo Zupelari GoncalvesAnn Arbor$21K
- Erik WarrenMadison Heights$17K
- Bradley VanhooseCaledonia$11K
- Justine MoeOkemos$10K
- David LiptonMadison Heights$9K
- Jonattan AnguloWarren$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.